It's official. According to an article just published on the Foundation Fighting Blindness website, phase I gene therapy clinical trials for the type of LCA caused by RPE65 are scheduled to begin in fall 2005. This is wonderful news. You can read about this and more here
And stay tuned for more!
Thursday, February 24, 2005
Gene therapy clinical trials will begin this fall!
Subscribe to:
Posts (Atom)
